Shi, Yi,Lipari, John M.,Padden, Brian E.,Dias, Lloyd E.,Spence, Julie K.
申请号：
AU2012352112
公开号：
AU2012352112A1
申请日:
2012.12.14
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
A composition comprises a kinase inhibitory compound, e.g., N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N'-(3-fluorophenyl)urea, in a mixture comprising (a) a pharmaceutically acceptable water-soluble polymeric carrier and (b) a pharmaceutically acceptable surfactant. The composition is suitable for dilution with an IV solution for administration to a subject in need thereof for treatment of a cancer.
